A Global Milestone in Innovative Pancreatic Cancer Therapy

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BioGate-Precision-UK

More Like This

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

GlobeNewswire associated0

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

PR Newswire associated0

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

PR Newswire associated0

Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer

Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health

PR Newswire associated0

Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency